InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Ali Behbahani, Director,TenPercentOwner, is a corporate insider tracked by InsiderTape across 8 companies. The public record shows 11 open-market SEC Form 4 transactions: 6 purchases worth $34.0M and 5 sales worth $982K, reported from Oct 18, 21 to Feb 9, 26. Over this period they have been a mix of buying and selling.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 9, 26 | SGPSpyGlass Pharma, Inc. | BUY | 937.5K | $16.00 | $15.0M |
| Oct 2, 25 | NEUENeueHealth, Inc. | SELL | 2.5K | $6.75 | $17K |
| Aug 18, 25 | ADAPAdaptimmune Therapeutics PLC | SELL | 14.67M | $0.01 | $147K |
| Aug 15, 25 | ADAPAdaptimmune Therapeutics PLC | SELL | 4.83M | $0.01 | $48K |
| Sep 16, 24 | MBXMBX Biosciences, Inc. | BUY | 500.0K | $16.00 | $8.0M |
| Jul 17, 23 | SVRASavara Inc | BUY | 333.3K | $3.00 | $1000K |
| Jul 5, 23 | BDTXBlack Diamond Therapeutics, Inc. | BUY | 1.00M | $5.00 | $5.0M |
| May 25, 22 | GNCAGENOCEA BIOSCIENCES, INC. | SELL | 4.45M | $0.08 | $356K |
| May 24, 22 | GNCAGENOCEA BIOSCIENCES, INC. | SELL | 5.93M | $0.07 | $415K |
| Apr 11, 22 | TRVITrevi Therapeutics, Inc. | BUY | 2.63M | $1.90 | $5.0M |
| Oct 18, 21 | TRVITrevi Therapeutics, Inc. | BUY | 1.85M | - | $0 |